Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAz4bPFYMuYmb8453xV33cPytgapZrVy5Z1aHLL-ISRPQ#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Ranolazine extended-release tablets are contraindicated in patients: Taking strong inhibitors of CYP3A [see Drug Interactions ( 7.1 Taking inducers of CYP3A [see Drug Interactions ( 7.1 With liver cirrhosis [see Use in Specific Populations (8.6 Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin, nelfinavir) ( 4 7.1 CYP3A inducers (e.g., rifampin, phenobarbital, St. John's wort) ( 4 7.1 Liver cirrhosis ( 4 8.6"" assertion.
- association subject drugbank:DB00243 assertion.
- association predicate treats assertion.
- association object DOID_5082 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00243 category Drug assertion.
- DOID_5082 category Disease assertion.
- association provided_by NeuroDKG assertion.